Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.

Name: Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Author: Deng, Rong

Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anticytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial To Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. — المؤلف: Deng, Rong — Antimicrobial agents and chemotherapy 20190422

المؤلف: Deng, Rong
النشر: Antimicrobial agents and chemotherapy 20190422
الموضوعات: Adult؛ Antibodies, Monoclonal؛ Antibodies, Viral؛ Antiviral Agents؛ Cytomegalovirus؛ Cytomegalovirus Infections؛ Dose-Response Relationship, Drug؛ Drug Administration Schedule